-
<![CDATA[Lung Carcinoid Tumors: Diagnosis, Staging and Treatment Options]]>
31 Jan 2026 19:20 GMT
… therapies or clinical trial options may be … treatment and monitoring.
Frontline:
Systemic therapy is the primary approach. Somatostatin … treatment options, side effects, follow-up care and whether clinical trials … substitute for professional medical advice, as …
-
Humanwell Pharmaceutical patents new somatostatin SST4 receptor agonists for pain
30 Jan 2026 18:55 GMT
-
Nanjing Chia Tai Tianqing Pharmaceutical identifies new somatostatin SST2 receptor agonists
19 Jan 2026 18:05 GMT
-
Prior Hypoglycemia Boosts Somatostatin, Weakens Glucagon
13 Jan 2026 14:14 GMT
… conditions. By revealing that somatostatin hypersecretion underlies impaired glucagon … activity could recalibrate the somatostatin feedback loop, potentially … medicine strategies. By targeting the nuanced interplay between α, β, and δ cells, future treatments …
-
Perspective Therapeutics Presents Updated Interim Data of [212Pb]VMT-α-NET in its Ongoing Phase 1/2a Clinical Trial at the 2026 ASCO Gastrointestinal Cancers Symposium
09 Jan 2026 12:00 GMT
… trial of [212Pb]VMT-α-NET in patients with unresectable or metastatic somatostatin … medical intervention. The patient continues to receive [212Pb]VMT-α-NET treatment … 2a imaging and therapy trials in the U. … regional network of drug product candidate finishing …
-
<![CDATA[CAR-T and Radioligand Therapies for Treatment of NETS]]>
07 Jan 2026 14:25 GMT
… T-cell therapy and antibody-drug conjugates. Dr. Arshad emphasized that … the treatment landscape by targeting tumor-specific antigens such as somatostatin … therapies and antibody-drug conjugates poised to expand treatment options for patients …
-
FDA Drug Approvals Q3 2025
06 Jan 2026 17:43 GMT
… -label, nonrandomized clinical trials that evaluated adults and … delivery of drug in the bladder for treatment of bacillus … to the natural hormone somatostatin, paltusotine suppresses growth hormone … no longer as adjunct to statin therapy)
Repatha (evolocumab)— …
-
<![CDATA[Q1 2026: 5 FDA Decisions to Watch in the Realm of Oncology]]>
06 Jan 2026 15:16 GMT
… could introduce new treatment options and reshape … the phase 3 ALLELE trial (NCT03394365), tabelecleucel demonstrated … PET Imaging of Somatostatin Receptor–Positive Neuroendocrine Tumors … -pharmaceutical-announce-us-fda-acceptance-of-supplemental-new-drug- …
-
<![CDATA[Q1 2026: 5 FDA Decisions to Watch in Oncology]]>
02 Jan 2026 18:11 GMT
… for Tabelecleucel for the Treatment of Epstein-Barr Virus … : European Society of Medical Oncology Congress 2025; … Pharmaceutical Announce U.S. FDA Acceptance of Supplemental New Drug … Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) …
-
Efficacy and Safety Comparison of Ulinastatin versus Flurbiprofen Axetil for Preemptive Analgesia in Reducing Opioid Burden After Total Knee Arthroplasty: A Randomized Controlled Trial [Response to Letter]
31 Dec 2025 14:08 GMT
… agree that future trials should incorporate additional … Ulinastatin combined with somatostatin enhances disease control … treatment of severe acute pancreatitis: a single-center randomized controlled trial … multiple anti-inflammatory drugs strategy on …